VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q4 2014 13F Holders as of 31 Dec 2014
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 229,712,105
- Share change
- -4,160,577
- Total reported value
- $27,292,739,520
- Put/Call ratio
- 157%
- Price per share
- $118.80
- Number of holders
- 467
- Value change
- -$488,784,588
- Number of buys
- 223
- Number of sells
- 183
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
10%
|
25,657,177
|
$2,881,558,000 | — | 30 Sep 2014 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.8%
|
19,858,460
|
$2,230,304,000 | — | 30 Sep 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.8%
|
17,236,333
|
$1,935,813,000 | — | 30 Sep 2014 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.6%
|
14,190,762
|
$1,593,764,000 | — | 30 Sep 2014 | |
| FMR LLC |
13F
|
Company |
5.5%
|
14,020,693
|
$1,574,664,000 | — | 30 Sep 2014 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.2%
|
10,591,405
|
$1,189,520,000 | — | 30 Sep 2014 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
4.1%
|
10,448,752
|
$1,173,499,000 | — | 30 Sep 2014 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
9,753,761
|
$1,095,450,000 | — | 30 Sep 2014 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.7%
|
9,497,863
|
$1,066,708,000 | — | 30 Sep 2014 | |
| Clearbridge Investments, LLC |
13F
|
Company |
3%
|
7,599,171
|
$853,463,000 | — | 30 Sep 2014 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
2.4%
|
6,191,935
|
$695,416,000 | — | 30 Sep 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
2.2%
|
5,608,525
|
$629,893,000 | — | 30 Sep 2014 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.5%
|
3,837,000
|
$430,933,000 | — | 30 Sep 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
3,585,254
|
$402,659,000 | — | 30 Sep 2014 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
3,176,616
|
$356,766,000 | — | 30 Sep 2014 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
2,851,470
|
$320,249,000 | — | 30 Sep 2014 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
2,591,677
|
$291,071,000 | — | 30 Sep 2014 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.99%
|
2,524,532
|
$283,529,000 | — | 30 Sep 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.96%
|
2,434,018
|
$273,361,000 | — | 30 Sep 2014 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.94%
|
2,398,132
|
$269,334,000 | — | 30 Sep 2014 | |
| BlackRock Group LTD |
13F
|
Company |
0.86%
|
2,191,313
|
$246,106,000 | — | 30 Sep 2014 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.84%
|
2,131,679
|
$239,409,000 | — | 30 Sep 2014 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.8%
|
2,034,383
|
$228,482,000 | — | 30 Sep 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
1,745,225
|
$195,756,000 | — | 30 Sep 2014 | |
| NORGES BANK |
13F
|
Company |
0.6%
|
1,540,270
|
$172,988,000 | — | 30 Sep 2014 | |
| BB BIOTECH AG |
13F
|
Company |
0.53%
|
1,354,445
|
$152,118,000 | — | 30 Sep 2014 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.53%
|
1,350,000
|
$151,619,000 | — | 30 Sep 2014 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.53%
|
1,344,532
|
$151,004,000 | — | 30 Sep 2014 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.51%
|
1,290,134
|
$144,860,000 | — | 30 Sep 2014 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.44%
|
1,122,173
|
$126,031,000 | — | 30 Sep 2014 | |
| MANAGED ACCOUNT ADVISORS LLC |
13F
|
Company |
0.44%
|
1,117,558
|
$125,513,000 | — | 30 Sep 2014 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.44%
|
1,107,967
|
$124,436,000 | — | 30 Sep 2014 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.43%
|
1,098,089
|
$123,326,000 | — | 30 Sep 2014 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.41%
|
1,049,868
|
$117,911,000 | — | 30 Sep 2014 | |
| Legal & General Group Plc |
13F
|
Company |
0.37%
|
936,930
|
$105,227,000 | — | 30 Sep 2014 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.36%
|
915,627
|
$102,834,000 | — | 30 Sep 2014 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.36%
|
914,974
|
$102,760,000 | — | 30 Sep 2014 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.35%
|
883,226
|
$99,195,000 | — | 30 Sep 2014 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.29%
|
747,686
|
$83,973,000 | — | 30 Sep 2014 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.28%
|
701,944
|
$78,835,000 | — | 30 Sep 2014 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.28%
|
701,033
|
$78,733,000 | — | 30 Sep 2014 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.27%
|
698,039
|
$78,397,000 | — | 30 Sep 2014 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.26%
|
674,485
|
$75,751,000 | — | 30 Sep 2014 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.26%
|
674,007
|
$75,698,000 | — | 30 Sep 2014 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.26%
|
669,776
|
$75,223,000 | — | 30 Sep 2014 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.26%
|
661,813
|
$74,328,000 | — | 30 Sep 2014 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.25%
|
627,481
|
$70,472,473 | — | 30 Sep 2014 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.22%
|
552,653
|
$62,068,000 | — | 30 Sep 2014 | |
| TOBAM |
13F
|
Company |
0.2%
|
515,475
|
$57,893,000 | — | 30 Sep 2014 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.2%
|
514,156
|
$57,746,000 | — | 30 Sep 2014 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2014
As of 31 Dec 2014,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
467 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
229,712,105 shares.
The largest 10 holders included
Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, State Street Corp, Ameriprise Financial Inc, Clearbridge Investments, LLC, and JENNISON ASSOCIATES LLC.
This page lists
467
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2014 vs Q3 2014 Across Filers
Q3 2014 holders
424
Q4 2014 holders
467
Holder diff
43
| Investor | Q3 2014 Shares | Q4 2014 Shares | Share Diff | Share Chg % | Q3 2014 Value $ | Q4 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.